PTC Therapeutics, Inc. (PTCT) Operating margin 2016–2025
PTC Therapeutics, Inc. (PTCT) operating margin by fiscal year — reported operating income divided by reported revenue.
50.1%FY2025 · since FY2016: -159.7% → 50.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 50.1% | +87.6 pp |
| FY2024 | -37.5% | +9.4 pp |
| FY2023 | -46.9% | +17.2 pp |
| FY2022 | -64.0% | +5.5 pp |
| FY2021 | -69.5% | +43.9 pp |
| FY2020 | -113.4% | -34.8 pp |
| FY2019 | -78.6% | -34.9 pp |
| FY2018 | -43.7% | -10.6 pp |
| FY2017 | -33.1% | +126.6 pp |
| FY2016 | -159.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice